放射科医生需知:非肌层浸润性、肌层浸润性和转移性膀胱癌的更新
综述讨论膀胱癌亚型的遗传与分子特征及新治疗进展,强调影像在非肌层浸润性、肌层浸润性和转移性膀胱癌诊断、分期和随访中的作用,提醒放射科医生更新命名与诊疗标准。
要点
- 影像在膀胱癌诊断、分期和随访中具有重要作用。
- 放射科医生需更新膀胱癌命名与诊疗标准。
- 综述涵盖非肌层浸润性、肌层浸润性和转移性膀胱癌的影像贡献。
核心结论
- 膀胱癌亚型的遗传与分子特征及新治疗进展不断涌现,放射科医生需更新命名与诊疗标准。
- 影像在非肌层浸润性、肌层浸润性和转移性膀胱癌的诊断、分期和随访中具有重要作用。
研究设计与样本
- 综述,讨论膀胱癌特征与治疗的最新进展,并参考影像在非肌层浸润性、肌层浸润性和转移性膀胱癌中的贡献。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Urothelial bladder cancer is a common malignancy requiring a multidisciplinary approach to treatment. Significant recent advances have been made in terms of the genetic and molecular characterization of bladder cancer subtypes, and novel treatment approaches are being investigated and approved. Given the important role of imaging in the diagnosis, staging, and follow-up of this disease, it is necessary for radiologists to remain up-to-date in terms of nomenclature and standards of care. In this review, recent developments in bladder cancer characterization and treatment will be discussed, with reference to the contributions of imaging in non-muscle-invasive, muscle-invasive, and metastatic settings.
引用
- Choe J, Braschi-Amirfarzan M, Tirumani SH, et al. Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer. Abdom Radiol (NY). 2017. PMID: 28580540. doi:10.1007/s00261-017-1195-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。